Comparative study of biphasic calcium phosphate ceramics impregnated with rhBMP-2 as bone substitutes

Imranul Alam, Izumi Asahina, Kohichi Ohmamiuda, Shoji Enomoto

Research output: Contribution to journalArticle

89 Citations (Scopus)

Abstract

We investigated pellet-shaped implants prepared from biphasic calcium phosphate (BCP) ceramics with five different ratios of hydroxyapatite (HAP) to β-tricalcium phosphate (β-TCP) to evaluate these ceramics as bone substitutes. BCP ceramics impregnated with different doses of recombinant human bone morphogenetic protein 2 (rhBMP-2) (1, 5, and 10 μg) were used for experimental purposes and ceramics without rhBMP-2 were used for control. The pellets were implanted under the pericranium in adult Wistar male rats and were harvested 8 weeks after implantation. The retrieved pellets were then examined radiologically, histologically, and histomorphometrically. The results revealed that the pellets treated with rhBMP-2 exhibited new bone and bone marrow, whereas control pellets produced fibrous connective tissues. The formation of new bone induced by rhBMP-2 was dose dependent. The extent of bone and bone marrow formation and the degree of resorption of the ceramic particles were significantly higher in the pellets composed of 25% HAP-75% TCP. In this study, bioresorption of the ceramic produced favorable conditions for rhBMP-2-induced bone formation. (C) 2000 John Wiley and Sons, Inc.

Original languageEnglish (US)
Pages (from-to)129-138
Number of pages10
JournalJournal of Biomedical Materials Research
Volume54
Issue number1
DOIs
StatePublished - Jan 2001
Externally publishedYes

Fingerprint

Bone Substitutes
Calcium phosphate
Bone
Proteins
Durapatite
Hydroxyapatite
hydroxyapatite-beta tricalcium phosphate
recombinant human bone morphogenetic protein-2
Rats
Tissue
Phosphates

Keywords

  • Biphasic calcium phosphate
  • Bone morphogenetic protein
  • Bone substitute
  • HAP/TCP pellet
  • New bone formation

ASJC Scopus subject areas

  • Biomedical Engineering
  • Biomaterials

Cite this

Comparative study of biphasic calcium phosphate ceramics impregnated with rhBMP-2 as bone substitutes. / Alam, Imranul; Asahina, Izumi; Ohmamiuda, Kohichi; Enomoto, Shoji.

In: Journal of Biomedical Materials Research, Vol. 54, No. 1, 01.2001, p. 129-138.

Research output: Contribution to journalArticle

@article{c63900c125c041fbb0bb28bbfaaeddb8,
title = "Comparative study of biphasic calcium phosphate ceramics impregnated with rhBMP-2 as bone substitutes",
abstract = "We investigated pellet-shaped implants prepared from biphasic calcium phosphate (BCP) ceramics with five different ratios of hydroxyapatite (HAP) to β-tricalcium phosphate (β-TCP) to evaluate these ceramics as bone substitutes. BCP ceramics impregnated with different doses of recombinant human bone morphogenetic protein 2 (rhBMP-2) (1, 5, and 10 μg) were used for experimental purposes and ceramics without rhBMP-2 were used for control. The pellets were implanted under the pericranium in adult Wistar male rats and were harvested 8 weeks after implantation. The retrieved pellets were then examined radiologically, histologically, and histomorphometrically. The results revealed that the pellets treated with rhBMP-2 exhibited new bone and bone marrow, whereas control pellets produced fibrous connective tissues. The formation of new bone induced by rhBMP-2 was dose dependent. The extent of bone and bone marrow formation and the degree of resorption of the ceramic particles were significantly higher in the pellets composed of 25{\%} HAP-75{\%} TCP. In this study, bioresorption of the ceramic produced favorable conditions for rhBMP-2-induced bone formation. (C) 2000 John Wiley and Sons, Inc.",
keywords = "Biphasic calcium phosphate, Bone morphogenetic protein, Bone substitute, HAP/TCP pellet, New bone formation",
author = "Imranul Alam and Izumi Asahina and Kohichi Ohmamiuda and Shoji Enomoto",
year = "2001",
month = "1",
doi = "10.1002/1097-4636(200101)54:1<129::AID-JBM16>3.0.CO;2-D",
language = "English (US)",
volume = "54",
pages = "129--138",
journal = "Journal of Biomedical Materials Research",
issn = "1552-4973",
publisher = "Heterocorporation",
number = "1",

}

TY - JOUR

T1 - Comparative study of biphasic calcium phosphate ceramics impregnated with rhBMP-2 as bone substitutes

AU - Alam, Imranul

AU - Asahina, Izumi

AU - Ohmamiuda, Kohichi

AU - Enomoto, Shoji

PY - 2001/1

Y1 - 2001/1

N2 - We investigated pellet-shaped implants prepared from biphasic calcium phosphate (BCP) ceramics with five different ratios of hydroxyapatite (HAP) to β-tricalcium phosphate (β-TCP) to evaluate these ceramics as bone substitutes. BCP ceramics impregnated with different doses of recombinant human bone morphogenetic protein 2 (rhBMP-2) (1, 5, and 10 μg) were used for experimental purposes and ceramics without rhBMP-2 were used for control. The pellets were implanted under the pericranium in adult Wistar male rats and were harvested 8 weeks after implantation. The retrieved pellets were then examined radiologically, histologically, and histomorphometrically. The results revealed that the pellets treated with rhBMP-2 exhibited new bone and bone marrow, whereas control pellets produced fibrous connective tissues. The formation of new bone induced by rhBMP-2 was dose dependent. The extent of bone and bone marrow formation and the degree of resorption of the ceramic particles were significantly higher in the pellets composed of 25% HAP-75% TCP. In this study, bioresorption of the ceramic produced favorable conditions for rhBMP-2-induced bone formation. (C) 2000 John Wiley and Sons, Inc.

AB - We investigated pellet-shaped implants prepared from biphasic calcium phosphate (BCP) ceramics with five different ratios of hydroxyapatite (HAP) to β-tricalcium phosphate (β-TCP) to evaluate these ceramics as bone substitutes. BCP ceramics impregnated with different doses of recombinant human bone morphogenetic protein 2 (rhBMP-2) (1, 5, and 10 μg) were used for experimental purposes and ceramics without rhBMP-2 were used for control. The pellets were implanted under the pericranium in adult Wistar male rats and were harvested 8 weeks after implantation. The retrieved pellets were then examined radiologically, histologically, and histomorphometrically. The results revealed that the pellets treated with rhBMP-2 exhibited new bone and bone marrow, whereas control pellets produced fibrous connective tissues. The formation of new bone induced by rhBMP-2 was dose dependent. The extent of bone and bone marrow formation and the degree of resorption of the ceramic particles were significantly higher in the pellets composed of 25% HAP-75% TCP. In this study, bioresorption of the ceramic produced favorable conditions for rhBMP-2-induced bone formation. (C) 2000 John Wiley and Sons, Inc.

KW - Biphasic calcium phosphate

KW - Bone morphogenetic protein

KW - Bone substitute

KW - HAP/TCP pellet

KW - New bone formation

UR - http://www.scopus.com/inward/record.url?scp=0035202790&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035202790&partnerID=8YFLogxK

U2 - 10.1002/1097-4636(200101)54:1<129::AID-JBM16>3.0.CO;2-D

DO - 10.1002/1097-4636(200101)54:1<129::AID-JBM16>3.0.CO;2-D

M3 - Article

VL - 54

SP - 129

EP - 138

JO - Journal of Biomedical Materials Research

JF - Journal of Biomedical Materials Research

SN - 1552-4973

IS - 1

ER -